Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Erythropoietin Protects Very Preterm Infants Against Necrotizing Enterocolitis

NCT03919500 is registered in ClinicalTrials.gov with Zhengzhou University as lead sponsor.

NCT NCT03919500
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03919500 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Erythropoietin Protects Very Preterm Infants Against Necrotizing Enterocolitis
Lead sponsor
Zhengzhou University
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2014
Completion date
April 30, 2019
Enrollment
1,285 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

premature infant